In the serial sample analysis for the NSCLC cohort, we observed that patients with ≥3 months of ICB exposure demonstrated a decrease in clone size in gene mutations such as SRCAP, STK11 and TPM1 (Supplemental Figure S2). This evidence concerns the gene STK11 and non-small cell lung carcinoma.